Pharmaceuticals, Biotechnology and Life Sciences
Dr. Periman Joins Chairman Joseph Tauber as Advisory Board’s Second MemberSAN DIEGO, Oct. 05, 2021 (GLOBE NEWSWIRE) — AXIM Biotechnologies,…
CAMBRIDGE, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a…
LAWRENCEVILLE, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy…
MENLO PARK, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria…
Potential Indication Expansion for Telix’s Core Kidney Cancer Theranostic ProgramMELBOURNE, Australia and LIÈGE, Belgium, Oct. 05, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals…
PARIS and CAMBRIDGE, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), a clinical-stage…
NEW YORK, Oct. 04, 2021 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery…
DUBLIN, Ireland and FORT WASHINGTON, Pa., Oct. 04, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company…
Advances Development of Diagnostics for Sepsis-Causing Pathogens, Antibiotic Resistance, and Biothreat PathogensLEXINGTON, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) — T2…
ERYTECH Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer No…